• Access Pharmaceuticals Inc., of Dallas, entered definitive agreements with institutional and other investors for the private placement of $5.2 million of units consisting of Access common stock and warrants. Each unit consists of one share of Access common stock at $1.45 per share, with 50 percent warrant coverage with an exercise price of $1.67 per share and a term of 30 months and 50 percent warrant coverage with an exercise price of $2 per share and a term of five years. The transaction is expected to close on or about Nov. 7.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter